“Zanolimumab (HuMax-CD4®), a Fully Human Monoclonal Antibody in Clinical Development for Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports (formerly Haematologica Reports) 2, no. 5 (June 23, 2009). Accessed June 20, 2025. https://journals.pagepress.org/hmr/article/view/736.